H. Pandha

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

J. Blake Bartlett, A Michael, Ian Clarke et al. · British Journal of Cancer · 2004 · 139 citations · Full text

Immunology, Pathology, Revimid Trade Mark +16

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

Bhawna Sirohi, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 115 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy

Elizabeth J. Ilett, Tim Kottke, Jill Thompson et al. · Gene Therapy · 2016 · 71 citations · Full text

Anti-tumour Therapy, Medicine, Immunology +9

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling

Joan Kyula, Aadil Khan, David Mansfield et al. · Oncogene · 2013 · 43 citations

Cancer Immunosurveillance, Medicine, Pathogenesis +9

AN INTERLEUKIN-10 PROMOTER POLYMORPHISM MAY INFLUENCE TUMOR DEVELOPMENT IN RENAL CELL CARCINOMA

E.G. Havranek, W. Martin Howell, Helen Fussell et al. · The Journal of Urology · 2005 · 38 citations